Clinical Focus ›› 2024, Vol. 39 ›› Issue (1): 57-60.doi: 10.3969/j.issn.1004-583X.2024.01.010

Previous Articles     Next Articles

IgG4-related diseases characterized by increased IgE level and eosinophil count with multiple lymphadenopathy: A case report

Song Jialianga, Jiang Yingjieb, Kong Ruinac(), Cai Qingc, Gao Jiec   

  1. a. Department of Rehabilitation Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China
    b. Department of Pathology, Changhai Hospital, Naval Medical University, Shanghai 200433, China
    c. Department of Rheumatism and Immunology, Changhai Hospital, Naval Medical University, Shanghai 200433, China
  • Received:2022-07-12 Online:2024-01-20 Published:2024-03-22

Abstract:

Objective To explore the clinical features and treatment of immunoglobulin G4 (IgG4)-related diseases characterized by increased immunoglobulin E (IgE) level and eosinophilic count with multiple lymphadenopathy. Methods The clinical data, diagnosis and treatment process of a patient with IgG4-related disease characterized by increased IgE level and eosinophilic count with multiple lymphadenopathy were retrospective analyzed, and related literatures were reviewed. Results A 24-year-old male patient was admitted with the enlargement of bilateral inguinal lymph nodes for more than 2 years. The clinical manifestations, IgG4 test and pathology results suggested the diagnosis of IgG4-related disease. The therapeutic regimen was 20 mg prednisone orally once a day and 5 mg Tofacitinib citrate tablets orally twice a day. The dosage was adjusted according to the blood test and ultrasound results, and the symptoms of the patient were significantly improved at the final follow-up visit. Conclusion IgG4-related diseases are often characterized by significantly elevated serum IgG4 levels and lump-like lesions. Increased IgE level and eosinophil count are rarely observed in cases of IgG4-related diseases, although their important roles have been recently identified. Glucocorticoids are the first-line drugs, and targeted drugs like Tofacitinib may have potential therapeutic effects on IgG4-related diseases, which expand the new idea of the treatment.

Key words: immunoglobulin G4-related disease, immunoglobulin E, eosinophilia, lymph nodes

CLC Number: